Ethyl 6-fluoro-4-hydroxyquinoline-3-carboxylate, 95.0%, 250mg

1-(4-Bromophenyl)-2,5-dimethyl-1H-pyrrole, 95.0%, 10g

3-(3-Methoxyphenyl)butanoic acid, 98%, 2.5g

butyl[(2E)-3-(4-methoxyphenyl)prop-2-en-1-yl]amine hydrochloride, 95.0%, 10g

N-(2-Chloropyrimidin-4-yl)-2,3-dimethyl-2H-indazol-6-amine, 95.0%, 1g

2-Bromo-5-iodobenzamide, 98%, 1g

4-[[(2-methylpropyl)amino]methyl]phenylboronic acid, 98+%, 1g

1-(BENZENESULFONYL)-2-METHYL-1H-PYRROLO[2,3-B]PYRIDIN-5-AMINE, 95.0%, 1g

N-(3-Fluoro-4-methyl-8-oxo-5,6,7,8-tetrahydronaphthalen-1-yl)acetamide, 98%, 100g

N-Octyl-2-pyrrolidone (NOP), SOLVAGREEN® min.99%, pour la synthèse, 2,5 l, emballage plastique.

1,2,3,4,5-Pentamethylcyclopentadiene>93.0%(GC)25mL

Methylnaltrexone Bromide>95.0%(HPLC)(qNMR)10mg

3,5-Dimethyl-1-phenyl-1H-pyrazole-4-carbaldehyde, 95.0%, 1g